BioTime raises $3.5M in offering

BioTime (BTX) brings in $3.5M after selling 70,000 shares of Series A Preferred Stock.

Each share yields 3% per annum or $1.50/share and is convertible into common at $4.00.

Purchasers of the preferred shares also received an option to convert the shares into LifeMap Sciences common stock at the ratio of 1:12.5 for a period of five years.

Proceeds will be used to finance product development activities at LifeMap, a BioTime subsidiary.

80 mutual funds have positions in the stock.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs